Compare, Analyse Cadila Healthcare with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs MYLAN (US) - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   MYLAN
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
MYLAN
Dec-18
CADILA HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs5583,383-   
Low Rs3621,862-   
Sales per share (Unadj.) Rs116.31,556.9-  
Earnings per share (Unadj.) Rs17.942.3-  
Cash flow per share (Unadj.) Rs23.1333.8-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.41,684.2-  
Shares outstanding (eoy) m1,023.74514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.7 234.7%   
Avg P/E ratio x25.762.0 41.5%  
P/CF ratio (eoy) x19.97.9 252.9%  
Price / Book Value ratio x5.41.6 345.6%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,6641,349,457 34.9%   
No. of employees `00011.835.0 33.8%   
Total wages/salary Rs m18,5450-   
Avg. sales/employee Rs Th10,072.722,885.7 44.0%   
Avg. wages/employee Rs Th1,569.10-   
Avg. net profit/employee Rs Th1,547.7621.4 249.0%   
INCOME DATA
Net Sales Rs m119,049801,001 14.9%  
Other income Rs m1,1320-   
Total revenues Rs m120,181801,001 15.0%   
Gross profit Rs m28,475207,269 13.7%  
Depreciation Rs m5,388149,979 3.6%   
Interest Rs m91138,525 2.4%   
Profit before tax Rs m23,30818,765 124.2%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644-2,985 -189.1%   
Profit after tax Rs m18,29221,750 84.1%  
Gross profit margin %23.925.9 92.4%  
Effective tax rate %24.2-15.9 -152.2%   
Net profit margin %15.42.7 565.8%  
BALANCE SHEET DATA
Current assets Rs m82,005447,278 18.3%   
Current liabilities Rs m60,720326,115 18.6%   
Net working cap to sales %17.915.1 118.2%  
Current ratio x1.41.4 98.5%  
Inventory Days Days7384 87.5%  
Debtors Days Days9893 105.3%  
Net fixed assets Rs m83,703155,381 53.9%   
Share capital Rs m1,024426 240.1%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,445866,536 10.1%   
Long term debt Rs m25,551935,271 2.7%   
Total assets Rs m180,6532,324,387 7.8%  
Interest coverage x26.61.5 1,787.7%   
Debt to equity ratio x0.31.1 27.1%  
Sales to assets ratio x0.70.3 191.2%   
Return on assets %10.62.6 409.9%  
Return on equity %20.92.5 833.4%  
Return on capital %22.03.2 691.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,193166,448 5.5%  
From Investments Rs m-9,737-86,035 11.3%  
From Financial Activity Rs m515-77,541 -0.7%  
Net Cashflow Rs m-291,379 -2.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare CADILA HEALTHCARE With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: STRIDES PHARMA SCIENCE  JUBILANT LIFE SCIENCES  FDC LTD.  NOVARTIS  SUN PHARMA  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Oct 18, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - UNICHEM LAB COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS